Advances in Pharmacovigilance for Herbal Medicines
Date
12th - 14th April 2023
Venue
Royal Botanic Gardens, Kew, London, United Kingdom
- Conference Overview
- Key Speakers
- Conference Programme
- Tutorial Programme
- Aims of the Conference
- Who Should Attend
- Key Topics
- Call for Abstracts
- Registration & Fees
- Book Now
Conference Overview
The use of herbal and traditional medicines for health and well-being, as well as for prevention and treatment of disease, remains a popular choice globally. While herbal and traditional medicines may bring health benefits, as with other medicinal products, there are also associated risks, including a lack of clinical pharmacokinetic and pharmacodynamic data to determine dosages, dose-response relationships and other parameters, as well as poor-quality products. Developments in regulation for herbal and traditional medicines have strengthened pharmacovigilance for these products, but there are challenges in identifying, assessing, monitoring and managing safety concerns.
Key Speakers
- Dr Jeff Aronson, Centre for Evidence Based Medicine, Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK
- Mark Blumenthal / Stefan Gafner, American Botanical Council
- Professor Jo Barnes, Associate Professor in Herbal Medicines, School of Pharmacy, University of Auckland, New Zealand
- Professor Ian CK Wong, Lo Shiu Kwan Kan Po Ling Professor in Pharmacy, Head of Department of Pharmacology and Pharmacy, The University of Hong Kong
- Dr Bob Allkin, The Royal Botanic Gardens, Kew, London, UK
- Professor Souad Skalli, Associate Professor, Faculty of Science, University Mohammed V in Rabat, Rabat, Morocco
- Rich Boyce, Associate Professor of Biomedical Informatics and Clinical and Translational Science, Clinical and Translational Science Institute, and Associate Director, Biomedical Informatics Training Program, University of Pittsburgh, USA
- Amy Roe, Director Principal Toxicologist, Personal Health Care, Procter & Gamble, USA
- Daniele Sartori, Pharmacovigilance Scientist, Uppsala Monitoring Centre, Uppsala, Sweden / PhD Student, Centre for Evidence-Based Medicine, Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK
- Florence van Hunsel, Head Signal Detection, Netherlands Pharmacovigilance Centre (LAREB)
- Phil Rasmussen, Founding Director, Natural Health Products New Zealand
Conference Programme
Tutorial Programme
Coming soon
Aims of the Conference
This conference aims to provide a comprehensive and critical update on advances in pharmacovigilance activities for herbal and traditional medicines at the national and global levels. The conference will explore challenges in pharmacovigilance for herbal and traditional medicines, developments and new approaches in safety monitoring for these products, various stakeholder perspectives, and future directions.
Who Should Attend
The conference is aimed at individuals working in/as:
- Medicines regulatory authorities and pharmacovigilance centres
- Pharmaceutical industry settings, including the herbal/phytomedicines/complementary medicines industry, particularly those working in pharmacovigilance, medical information, regulatory affairs, product development and marketing
- Academia, particularly in pharmacovigilance/pharmacoepidemiology, pharmacognosy, phytotherapy/herbal medicines, undergraduate and postgraduate health professional programmes
- Pharmacists, doctors, nurses and other health professionals
- Herbal/traditional medicine practitioners and other ‘natural health’/complementary medicine practitioners
- Herbal/traditional medicine practitioners and other ‘natural health’/complementary organisations
- Representatives from non-governmental organisations, such as patient- and health-oriented charities
Key Topics
- Methodological developments and new approaches in pharmacovigilance for herbal medicines
- Patients’ perspectives in pharmacovigilance for herbal medicines
- Towards ‘big data’ for herbal and traditional medicines
- Challenges in coding and classification for herbal and traditional medicines
- Quality of herbal and traditional medicines and implications for safety and pharmacovigilance
- Industry, practitioner and regulatory perspectives in pharmacovigilance for herbal and traditional medicines
Call for Abstracts
Abstracts are invited for submission in the key topics listed above and in other areas relevant to pharmacovigilance for herbal and traditional medicines. Abstracts will be accepted for poster or oral presentations. Posters will be displayed on one or both days of the conference, depending on final numbers of accepted abstracts. A small number of high-quality accepted abstracts will be invited to be presented as a short oral presentation (10 minutes plus 5 minutes for questions). If you would like your abstract to be considered for a short oral presentation rather than a poster, please indicate this on the abstract submission form. Accepted abstracts submitted by presenters who have paid their conference registration fee will be published in the journal Drug Safety.
The abstract submission deadline: 12am GMT on Sunday 5 February 2023
Accepted abstracts notification: 11pm GMT on Wednesday 1 March 2023
Abstracts submit to: confabstracts@dsru.org
Presenters of accepted abstracts are required to register for the conference and must pay the appropriate registration fee.
The registration deadline for presenters: 5pm GMT on Wednesday 15th March 2023
Registration & Fees
You can book the conference on its own or with one or both pre-conference tutorials.
Pre-conference tutorial A: Herbal Medicines (morning)
Pre-conference tutorial B: Pharmacovigilance and Pharmacoepidemiology (afternoon)
VAT not applicable for bookings made outside of the UK.
